Inclusion Factors: MS diagnosis by 2010 McDonald criteria, any form of MS 55 years or older, no maximum age No relapse within last 5+ years No new MRI lesion in…
Read More
MRI Scan Change or Relapse: Over 90% of participants overall (across both groups) did not have new MRI scan changes or relapse. Relapses were especially uncommon. 4 people out of…
An Interview with Dr. John Corboy, Medical Director of the Rocky Mountain MS Center The DISCO-MS trial — short for “discontinuing” MS medications — looked at the question “Can we…
Research efforts at the Rocky Mountain MS Center at University of Colorado have been at the forefront of multiple sclerosis care and treatment for decades, but in all those years…
The DISCO-MS trial looked at the question “Can we define a population of patients in whom it’s safe to discontinue their disease modifying therapy (DMT) for MS as they age?”…
Dr. Timothy Vollmer hosts an informal discussion of the state of MS research today. Recorded on May 19, 2022. Dr. Vollmer talks about remyelination prospects, treatments for progressive MS, neurofilament…
The Rocky Mountain Neurology Translational Research Laboratory has been up and running for about two years now, with researchers from the Rocky Mountain MS Center at CU taking the lead…
Over the years, research has grown to become a cornerstone of the work of the Rocky Mountain MS Center at University of Colorado. As treatments have become more numerous and…
Early and accurate diagnosis of MS is probably the most important component of MS treatment — getting patients on effective therapies as quickly as possible has a dramatic effect on…
As we develop treatment strategies that rely on early diagnosis, it’s more important than ever that we identify MS as quickly as possible — and that means watching for common…
You're Reading:
About the Author
Kerri Cechovic is the Director of Programs at the Rocky Mountain MS Center, and one of the key authors for InforMS Magazine.